Scorpio competitive analysis

Explore patent oppositions filed by Scorpio against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Apr 23, 2026
Patent NumberTitleApplicantOpposition Date
Combination Therapy For Inhalation AdministrationCHEMO RESEARCHFeb 27, 2026
Antimicrobial Compounds From The Genus DelftiaMINISTRY OF HEALTHOct 1, 2025
Iron Complex Compounds For Therapeutic UsePHARMACOSMOS HOLDINGSep 30, 2025
Process For Preparing High Purity Degree LarotrectinibOLONJul 16, 2025
Novel Pharmaceutical CompositionNOVARTISJan 9, 2025
Crastalline Hydrobromide Salt Of 5-Meo-DmtGH RESEARCH IRELANDDec 4, 2024
Bispecific Antibodies Against Cd3Epsilon And Bcma For Use In Treatment Of DiseasesBRISTOL MYERS SQUIBBMay 16, 2024
Method For Preparing Tert-Butyl N-((1R,2S,5S)-2-((2-((5-Chloropyridin-2-Yl)Amino)-2-Oxoacetyl)Amino)-5-(Dimethylcarbamoyl)Cyclohexyl)CarbamateMOEHS IBRICADec 8, 2023
Crystalline L-Arginine Salt Of (R)-2-(7-(4-Cyclopentyl-3-(Trifluoromethyl)Benzyloxy)-1,2,3,4-Tetrahydrocyclo-Penta[B]Indol-3-Yl)Acetic Acid(Compound1) For Use In Sipi Receptor-Associated DisordersARENA PHARMACEUTICALSJun 14, 2023
Rapid-Acting Insulin CompositionsELI LILLYDec 30, 2022

Latest PTAB cases involving Scorpio

Discover the latest PTAB cases involving Scorpio, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Scorpio with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Apr 23, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SCORPIO22 - - -
BAXALTA520 - -
ELI LILLY4251715
PURECIRCLE USA - 3 - 1